Autotransfusion Devices Market To Surpass USD 419.3 Million By 2032 | Livanova Plc Medtronic Haematonics Corporation

The global autotransfusion devices market was valued at USD 255 million in 2022 and it is anticipated to grow further till USD 419.3 million by 2032, at a CAGR of 5.1% during the forecast period.

To collect and re-infuse the patient’s blood, autotransfusion devices are frequently employed. The use of autologous blood transfusions to prevent infections brought on by allogeneic blood transfusions is made possible by these systems, which play a significant part in cell salvage approaches. These tools are used in invasive procedures for the heart, the joints, the nervous system, obstetrics, and gynecology. Systems can be divided into intraoperative systems, post-operative systems, and dual-mode systems based on how usable they are.

Get Access to A Free Sample Copy of Our Latest Report –

Market Trends and Drivers

Some of the major drivers anticipated to propel market expansion during the projected period include an increase in surgical operations, an increase in the number of surgical cases, and an increase in the number of liver or other organ transplant surgeries. Additionally, it is predicted that the market would expand due to the growing older population in the world as well as increased demand for cardiac devices. The rise in blood illnesses, the number of trauma and accident cases, and technological advancements all contribute to the growth of the blood transfusion device.

Major Players in the Global Autotransfusion Devices Market

The key players studied in the report are LivaNova PLC (U.K.), Medtronic (Ireland), Haematonics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), BD (Becton, Dickinson, and Company) (U.S.), Beijing Jingjing Medical Equipment Co., Ltd. (China), and ProCell Surgical Inc. (U.S.) among others.

COVID-19 Impact

The expansion of the autotransfusion devices market was adversely affected by the COVID-19 pandemic epidemic. It demonstrated a significant drop in revenue as a result of fewer surgical procedures being conducted. These tools are primarily utilized during heavy blood loss procedures, like orthopedic and heart surgery. The need for autologous blood transfusion equipment has decreased along with the decline in surgical procedures. For instance, the COVID-19 pandemic was said to have caused a 48% decrease in the total number of surgical procedures carried out in the United States, according to data published by the American Medical Association. However, the number of surgical procedures rebounded to normal levels once the pandemic limitations were lifted.

Get Customized Report as Per Your Requirement –

Global Autotransfusion Devices Segmentation

By Product

  • Autotransfusion Systems
  • Consumables & Accessories

By Application

  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Obstetrics & Gynecological Surgeries
  • Others

By End User

  • Hospitals
  • Specialty Clinics & Others

Buy Now –

With Global Insight Services, you receive:

  • 10-year forecast to help you make strategic decisions
  • In-depth segmentation which can be customized as per your requirements
  • Free consultation with lead analyst of the report
  • Excel data pack included with all report purchases
  • Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700